Ignite Creation Date:
2025-12-26 @ 5:20 PM
Ignite Modification Date:
2025-12-29 @ 5:16 AM
Study NCT ID:
NCT06452706
Status:
RECRUITING
Last Update Posted:
2024-11-19
First Post:
2024-06-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-14
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-06
First Submit QC Date:
None
Study First Post Date:
2024-06-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-18
Last Update Post Date:
2024-11-19
Last Update Post Date Type:
ACTUAL